Loading company…
Mcs Med develops devices for emergency vascular care and cardiac circulatory support.
Mcs Med develops emergency vascular care and cardiac support devices, including the PulseVAD® interventional ventricular assist system and Mcsreboa® resuscitation aortic occlusion balloon. Founded in 2024, the company is based in Shaoxing, China. In July 2024, it raised angel funding from Puhua Capital, and in December 2025, it closed pre-Series A funding led by National Innovation Center for High Performance Medical Devices, with Originvest Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in